CRISPRMED25: Where Breakthroughs Converge

CRISPR technology stands at the forefront of medical innovation, offering unparalleled potential to revolutionise treatment for previously untreatable genetic disorders, as well as new therapies for cancer and chronic diseases.

The 2nd CRISPR Medicine Conference (CRISPRMED25) serves as a global hub, fostering collaboration and knowledge exchange among leading researchers in the field.

Unifying the Global CRISPR Community: Join a collaborative environment where researchers share the transformative power of gene editing for human health applications.

Focus on Therapeutic Advancements: Submit abstracts that showcase the development of CRISPR tools, applications, and assays specifically designed to propel CRISPR-based therapies forward.

Platform for Groundbreaking Research: Share your latest discoveries and gain valuable insights from esteemed colleagues pushing the boundaries of gene editing.

Cultivating Collaboration: Foster new connections and collaborations that will accelerate the development of life-saving CRISPR-based therapies.

Be Part of the Future of Medicine: Submit Your Abstract Today!

CRISPRMED25 presents a unique opportunity to showcase your groundbreaking research and contribute to the future of gene therapy. We look forward to receiving your abstract!

Conditions and guidelines for abstract submission

Conditions

  • Registration is mandatory before you may submit an abstract.

  • You may submit an abstract for either the in-person event (8th - 11th April 2025) or the virtual event (7th April 2025).

  • You can submit 1 abstract.

  • If you submit an abstract for the in-person event, your abstract may be selected for the poster session. The highest-scoring abstracts will be eligible for oral presentation.

  • If you submit an abstract for the virtual event, your abstract may be selected for the virtual poster session.

  • All accepted abstracts will be shared on CMN after the final programme is available.

The abstract submission deadline is the 17th of January 2025.

Guidelines

  • The abstract should contain a maximum of 500 words and should be written in English.

  • The abstract should be presented as cohesive, uninterrupted text.

  • The abstract should not be divided into separate sections such as "introduction, methods, results."

  • The abstract should provide a concise summary of the entire study, highlighting key aspects and findings.

  • Avoid using CAPITAL LETTERS for the entire title of your abstract.

  • List all authors' names with initials and surnames. Do not CAPITALISE the entire name.

  • Exclude acknowledgments or references from your abstract, as they will be included in the word count.

  • Select the subject area that best fits your abstract to guarantee the identification of appropriate reviewers for your work.

Please make sure the email provided will be valid throughout the reviewing process, as it will be used to contact you about the outcome of your submission.

My abstract has been submitted. Now what?

Your abstract will be reviewed by a panel of experts who will evaluate your work based on defined parameters.

The outcome will be communicated to you via email in the end of February 2025 using the email address you provide during abstract submission.

If you haven't received a notification by February 28th, please check your spam/junk folder or contact CRISPRMED25 staff at info@crisprmedicineconference.com.

In case you wish to withdraw your submission, please do so as early as possible.

​Confirmation by invited oral presenters

All delegates who have been notified of the acceptance of their abstract for oral presentation must confirm their intention to present as instructed in the email notification.